Fig. 2From: CA19‑9 is a significant prognostic factor in stage III gastric cancer patients undergoing radical gastrectomyPrognostic impact of pre- and postoperative CA19-9 levels in stage III GC. RFS curves (a) and OS curves (b)Back to article page